Updated daily
GLP-1 news and data changes
Last updated
Everything that changed in the data on this site, written from each source's own record and linked to it.
Latest change . RSS feed
5,207 changes on record: 181 FDA actions and label updates, 11 generic challenges and patent listings, 2 Medicare and Medicaid data releases, 2,143 cash price updates, 2,595 seller record updates, 68 recalls, 115 trial updates, 45 published studies, 47 reviews by us. In the last 7 days, 877 changes were at a source (a seller's price or terms, FDA, a label, a trial, a study) and 1,000 were sellers and facts we added, shown one line per seller. The sources are compared with the day before every day at 14:07 UTC, and each line is written from the source's own record.
Nov 16, 2026
- TrialSemaglutide study now recruiting (was not yet recruiting): GLP-1 Medication & Behavioral Health Programs on Weight & Metabolic Outcomes: FLOURISH and THRIVE Prospective Cohort Study (clinicaltrials.gov/study/NCT07588984)
- TrialResults posted for a Liraglutide study: SCALE KIDS: Research Study to Look at How Well a New Medicine is at Lowering Weight in Children With Obesity (clinicaltrials.gov/study/NCT04775082)
- TrialNew Survodutide study registered: A Study to Compare How Survodutide is Taken up by the Body When Given in 2 Formulations to People With Overweight or Obesity (clinicaltrials.gov/study/NCT07940244)
- TrialVK2735 study now recruiting (was not yet recruiting): Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3 (SUNRISE 2) (clinicaltrials.gov/study/NCT07868939)
- TrialVK2735 study now recruiting (was not yet recruiting): Oral VK2735 for Weight Management Phase 3 (SUNRISE 1) (clinicaltrials.gov/study/NCT07868835)
Nov 13, 2026
- TrialNew Semaglutide study registered: Safety and Pharmacokinetics of UI112 Compared With UIC202611 in Healthy Adults (clinicaltrials.gov/study/NCT07935200)
- TrialSemaglutide study now completed (was active, not recruiting): A Study of BGM0504 in Participants With Type 2 Diabetes (clinicaltrials.gov/study/NCT06716216)
Nov 12, 2026
- TrialNew Semaglutide study registered: GLP-1 Receptor Agonists in the Surgical Patient: Prevalence, Epidemiology, and Pulmonary Complications (clinicaltrials.gov/study/NCT07932119)
- TrialTirzepatide study now recruiting (was not yet recruiting): Tirzepatide in Thrombectomy-Treated Acute Ischemic Stroke: A Randomized Trial (clinicaltrials.gov/study/NCT07734792)
- TrialNew Tirzepatide study registered: Breath Acetone During Tirzepatide Treatment and Resistance Training in Adults With Obesity (clinicaltrials.gov/study/NCT07931235)
- TrialResults posted for a Tirzepatide study: A Study of Tirzepatide Compared With Intensified Conventional Care in Adult Participants With Type 2 Diabetes (clinicaltrials.gov/study/NCT05433584)
- TrialNew Tirzepatide study registered: Molecular and Microbiome Changes During Tirzepatide Treatment and Resistance Training in Obesity (clinicaltrials.gov/study/NCT07931196)
- TrialSemaglutide study now completed (was active, not recruiting): A Study to Test if Trevogrumab or Trevogrumab With Garetosmab When Taken With Semaglutide is Safe and How Well They Work in Adult Patients With Obesity for Weight Loss, Fat Loss, and Lean Mass Preservation (clinicaltrials.gov/study/NCT06299098)
- TrialSemaglutide study now recruiting (was active, not recruiting): A Study to Compare Different Doses of Tifeglipron (RO7795081) With Placebo or Semaglutide in People With Type 2 Diabetes (clinicaltrials.gov/study/NCT07112872)
- TrialNew Semaglutide study registered: AMBITION 3: A Research Study Investigating How Well Zenagamtide at Higher Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide in People With Type 2 Diabetes Treated With Metformin, SGLT2i, or Both (clinicaltrials.gov/study/NCT07931573)
- TrialSemaglutide study now recruiting (was not yet recruiting): Glucagon-Like Peptide-1 Receptor Agonists to Attenuate Metabolic Risk in Individuals With Duchenne Muscular Dystrophy (clinicaltrials.gov/study/NCT07642635)
- TrialNew Semaglutide study registered: A Research Study Investigating How Well Zenagamtide at Lower Dose Levels Lowers Blood Sugar and Body Weight Compared to Semaglutide at Lower Dose Levels in People With Type 2 Diabetes Treated With Metformin, Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i), or Both (clinicaltrials.gov/study/NCT07931599)
Nov 10, 2026
- TrialSemaglutide study now active, not recruiting (was not yet recruiting): AMAZE 8: A Research Study Investigating How Well the Medicine NNC0487-0111 Compared to Semaglutide Helps People With Excess Body Weight and Type 2 Diabetes Lose Weight (clinicaltrials.gov/study/NCT07400107)
- TrialSemaglutide study now completed (was active, not recruiting): A Phase III Clinical Study to Evaluate the Efficacy and Safety of GZR18 Injection in Adult Type 2 Diabetes Mellitus (clinicaltrials.gov/study/NCT06778967)
- TrialNew Tirzepatide study registered: Functional, Cognitive, and Behavioral Correlates of Resistance Training During Tirzepatide-Induced Weight Loss (clinicaltrials.gov/study/NCT07929571)
- TrialNew Semaglutide study registered: 24-hour Clear Liquid Diet vs. Standard Fasting for Upper Gastrointestinal Endoscopy in Patients Taking Agonists of the GLP-1 Receptor (clinicaltrials.gov/study/NCT07929233)
- TrialMazdutide study now recruiting (was not yet recruiting): QUARTET-DKD: Quadruple Therapy for Type 2 Diabetic Nephropathy (clinicaltrials.gov/study/NCT07775846)
Nov 9, 2026
- TrialSemaglutide study now recruiting (was not yet recruiting): Semaglutide in Youth With Autism Spectrum Disorder (clinicaltrials.gov/study/NCT07770152)
- TrialSemaglutide study now recruiting (was not yet recruiting): Pathogenesis of Chronic Kidney Disease Associated With Metabolic Dysfunction- Associated Fatty Liver Disease (MAFLD) and Treatment Response of Oral Semaglutide. (clinicaltrials.gov/study/NCT07391267)
- TrialNew Semaglutide study registered: Ocular Changes in Patients Using Tirzepatide or Semaglutide (clinicaltrials.gov/study/NCT07924618)
- TrialNew Semaglutide study registered: Exercise and Protein to Reduce Muscle Loss During GLP-1-Based Treatment in Type 2 Diabetes (clinicaltrials.gov/study/NCT07926152)
- TrialResults posted for a Retatrutide study: A Study of Retatrutide (LY3437943) on Renal Function in Participants With Overweight or Obesity and Chronic Kidney Disease With or Without Type 2 Diabetes (clinicaltrials.gov/study/NCT05936151)
- TrialMariTide study now recruiting (was not yet recruiting): Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight (clinicaltrials.gov/study/NCT07871409)
- TrialNew Mazdutide study registered: Efficacy, Safety and Cardiovascular Protection of Mazdutide in Type 1 Diabetes (clinicaltrials.gov/study/NCT07924553)
Nov 6, 2026
- TrialNew Semaglutide study registered: Validation & Intervention Testing for Aging, Longevity and Healthspan (clinicaltrials.gov/study/NCT07923630)
- TrialResults posted for a Semaglutide study: Lifestyle Counseling and Medication for Adolescent Weight Management (clinicaltrials.gov/study/NCT04873245)
- TrialNew Semaglutide study registered: A Phase 2 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of SAL0150 Tablets in Subjects With Type 2 Diabetes Mellitus (clinicaltrials.gov/study/NCT07923357)
- TrialNew MariTide study registered: Comparing the Extent to Which Maridebart Cafraglutide (AMG 133) is Made Available in the Body When Administered Using Two Subcutaneous Presentations After Multiple Doses (clinicaltrials.gov/study/NCT07921316)
Nov 5, 2026
- TrialNew Semaglutide study registered: A Research Study to Investigate How Well the Medicine CagriSema Lowers High Blood Pressure in People Living With High Blood Pressure and Obesity (clinicaltrials.gov/study/NCT07919405)
- TrialSemaglutide study now completed (was unknown): The Effect of Different Diets on Arterial Stiffness in Obese Patients on Semaglutide (clinicaltrials.gov/study/NCT04990024)
Nov 4, 2026
- TrialSemaglutide study now recruiting (was not yet recruiting): Semaglutide Dose Effects on Metabolic and Stress Hormone, Craving and Alcohol Use Outcomes (clinicaltrials.gov/study/NCT07772960)
- TrialTirzepatide study now recruiting (was not yet recruiting): AI-Assisted Lifestyle Intervention Versus Tirzepatide for Obesity and Newly Diagnosed Type 2 Diabetes (clinicaltrials.gov/study/NCT07697391)
- TrialTirzepatide study now recruiting (was not yet recruiting): A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes (clinicaltrials.gov/study/NCT07881458)
- TrialExenatide study now completed (was active, not recruiting): Islet Transplantation in Type 1 Diabetic Patients Using the University of Illinois at Chicago (UIC) Protocol (clinicaltrials.gov/study/NCT00679042)
Nov 3, 2026
- TrialNew Liraglutide study registered: The Effect of Liraglutide on Body Weight, Body Composition, Ectopic Lipid Accumulation and Insulin Sensitivity in Subjects With Overweight or Obesity Without Diabetes (clinicaltrials.gov/study/NCT07913685)
Nov 2, 2026
- TrialResults posted for a Semaglutide study: Research Study to Look at How Well Semaglutide Works in People Living With Heart Failure, Obesity and Type 2 Diabetes (clinicaltrials.gov/study/NCT04916470)
- TrialNew Semaglutide study registered: Brain and Obesity Longitudinal Development: Neurobiological Mechanisms of Semaglutide Treatment of Adolescent Obesity (clinicaltrials.gov/study/NCT07911046)
- TrialNew Semaglutide study registered: Changes in Body Composition Following Pharmacological Treatment for Obesity. (clinicaltrials.gov/study/NCT07908940)
- TrialNew Semaglutide study registered: Semaglutide for Weight Management During Hormone Therapy for Early Breast Cancer (clinicaltrials.gov/study/NCT07909889)
- TrialNew MariTide study registered: Comparing the Extent to Which Maridebart Cafraglutide is Made Available in the Body of Participants Living With Overweight or Obesity After Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) (clinicaltrials.gov/study/NCT07908316)
Oct 30, 2026
- TrialNew Tirzepatide study registered: Tirzepatide and Organ-specific Biological Aging (clinicaltrials.gov/study/NCT07906041)
- TrialNew Liraglutide study registered: A Study on the Safety and Clinical Efficacy of Guominkang in the Treatment of Diabetic Kidney Disease (clinicaltrials.gov/study/NCT07907965)
Oct 29, 2026
- TrialTirzepatide study now active, not recruiting (was recruiting): Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) and Diet in Inflammatory Bowel Disease (IBD) Patients (clinicaltrials.gov/study/NCT06774079)
- TrialTirzepatide study now active, not recruiting (was enrolling by invitation): An Open-Label Tirzepatide Trial for Comorbid Obesity and Stimulant Use Disorder (clinicaltrials.gov/study/NCT07693608)
Oct 28, 2026
- TrialNew Semaglutide study registered: Mechanisms of Weight Loss: Tirzepatide vs Semaglutide (clinicaltrials.gov/study/NCT07900074)
- TrialNew Semaglutide study registered: A Research Study Looking at Kidney and Heart Health in Adults With Type 2 Diabetes and Chronic Kidney Disease Treated With Semaglutide in China (clinicaltrials.gov/study/NCT07900438)
- TrialNew Semaglutide study registered: Two-Year Weight Loss With GLP-1 Medications Compared With Sleeve Gastrectomy in Adults With Obesity (clinicaltrials.gov/study/NCT07901777)
Oct 27, 2026
- TrialNew Mazdutide study registered: Mazdutide for Reducing Atrial Fibrillation Recurrence After Catheter Ablation in Obese Patients (clinicaltrials.gov/study/NCT07897305)
Oct 26, 2026
- TrialNew Tirzepatide study registered: Effects of Tirzepatide on Esophagogastric Junction Mechanics, Reflux Burden, and Gastric Physiology in Adults With Obesity (clinicaltrials.gov/study/NCT07893457)
- TrialLiraglutide study now completed (was unknown): Incretin and Treatment With Inhibition of Sodium-glucose Cotransporter-2 Combination Insights Into Mechanisms Implicated in Congestive Heart Failure: "NATRIURETIC" Trial (clinicaltrials.gov/study/NCT04535960)
Oct 23, 2026
- TrialLiraglutide study now completed (was active, not recruiting): A Trial to Investigate the Safety and Efficacy of Intra-articular 4P004 Injection in Subjects With Knee Synovitis and Osteoarthritis (clinicaltrials.gov/study/NCT07225829)
- TrialNew Semaglutide study registered: Lean Mass Changes With Semaglutide in Adults With Type 1 Diabetes and Overweight/Obesity. (clinicaltrials.gov/study/NCT07891156)
Oct 22, 2026
- TrialNew Tirzepatide study registered: A Clinical Study to Evaluate the Effects of Enicepatide Versus Tirzepatide in Participants With Type 2 Diabetes and Inadequate Blood Sugar Control on Oral Glucose-Lowering Medications (clinicaltrials.gov/study/NCT07889648)
- TrialNew Semaglutide study registered: Metabolic Effects of Switching From Injectable Semaglutide to Tirzepatide (clinicaltrials.gov/study/NCT07889453)
Oct 19, 2026
- TrialNew Semaglutide study registered: Semaglutide for the Treatment of Cannabis Use Disorder (clinicaltrials.gov/study/NCT07879612)
- TrialNew Semaglutide study registered: Semaglutide Health Outcomes and Patient Adherence in Australia (clinicaltrials.gov/study/NCT07881770)
- TrialNew Tirzepatide study registered: A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes (clinicaltrials.gov/study/NCT07881458)
- TrialNew Tirzepatide study registered: A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes (clinicaltrials.gov/study/NCT07881432)
- TrialNew Liraglutide study registered: A Real-world Study of Treatment Retention and Adherence to Secukinumab in Patients With Plaque Psoriasis (PsO) With or Without Glucagon-like Peptide-1 Receptor Agonist (GLP-1 RA) Co-therapy (clinicaltrials.gov/study/NCT07881783)
Oct 16, 2026
- TrialNew Semaglutide study registered: Dietary, Medication, and Endoscopic Interventions for Post-Bariatric Hypoglycemia (clinicaltrials.gov/study/NCT07878494)
Oct 15, 2026
- TrialNew Tirzepatide study registered: PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study (clinicaltrials.gov/study/NCT07874828)
- TrialNew Semaglutide study registered: Long-Term Effects of Semaglutide on Body Composition and Performance in Running (clinicaltrials.gov/study/NCT07874932)
- TrialNew Semaglutide study registered: Short Term Effects of Semaglutide on Body Composition and Performance (clinicaltrials.gov/study/NCT07874971)
Oct 14, 2026
- TrialNew Semaglutide study registered: FutureShape Family (clinicaltrials.gov/study/NCT07872904)
Oct 13, 2026
- TrialNew Aleniglipron study registered: Aleniglipron Hepatic Impairment Study (clinicaltrials.gov/study/NCT07872033)
- TrialSemaglutide study now completed (was not yet recruiting): Real-world Canadian Retrospective Study Evaluating Longitudinal Semaglutide Use on Cardio-Kidney-Metabolic Outcomes (clinicaltrials.gov/study/NCT07424430)
- TrialNew Semaglutide study registered: A Neuropsychobiological Approach to Optimize Patient Selection for GLP-1-based Pharmacotherapy for Weight Management Across the Binge Eating Spectrum (clinicaltrials.gov/study/NCT07870538)
- TrialNew MariTide study registered: Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight (clinicaltrials.gov/study/NCT07871409)
- TrialNew Semaglutide study registered: ELITE: Deep Profiling and Algorithmic Polytherapy to Map Individual Response in Healthy Aging (clinicaltrials.gov/study/NCT07871799)
Oct 9, 2026
- TrialNew Tirzepatide study registered: A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Tirzepatide Medication (clinicaltrials.gov/study/NCT07868354)
- TrialNew VK2735 study registered: Oral VK2735 for Weight Management Phase 3 (SUNRISE 1) (clinicaltrials.gov/study/NCT07868835)
- TrialNew VK2735 study registered: Oral VK2735 for Weight Management in Adults With Type 2 Diabetes Mellitus Phase 3 (SUNRISE 2) (clinicaltrials.gov/study/NCT07868939)
Oct 8, 2026
- TrialNew Semaglutide study registered: Maridebart Cafraglutide Versus Semaglutide in Participants With Type 2 Diabetes (clinicaltrials.gov/study/NCT07866066)
- TrialNew Tirzepatide study registered: Trial of Innovative Fat-loss Focused Approaches in Patients With Class I Obesity: a Comparative Study (clinicaltrials.gov/study/NCT07866183)
Oct 7, 2026
- TrialSemaglutide study now completed (was recruiting): Semaglutide in Women With Polycystic Ovary Syndrome and Obesity (clinicaltrials.gov/study/NCT06896981)
Oct 5, 2026
- TrialNew Semaglutide study registered: Semaglutide Given Before and After Conversion of Sleeve Gastrectomy to Roux-en-Y Gastric Bypass for Recurrent Weight Gain (clinicaltrials.gov/study/NCT07859163)
- TrialNew Semaglutide study registered: Immediate Versus Criterion-triggered Semaglutide for Suboptimal Clinical Response One Year After Primary Metabolic and Bariatric Surgery (clinicaltrials.gov/study/NCT07859189)
- TrialNew Semaglutide study registered: Semaglutide Before Primary Metabolic and Bariatric Surgery in Patients With BMI 60 kg/m² or Higher (clinicaltrials.gov/study/NCT07859137)
- TrialNew Semaglutide study registered: Patient-centred Intervention With Virtual Support for Obesity and Kidney Transplant Access (clinicaltrials.gov/study/NCT07858331)
- TrialNew Semaglutide study registered: Semaglutide 2.4 mg Once Weekly for Recurrent Weight Gain After Metabolic and Bariatric Surgery (RESURGE) (clinicaltrials.gov/study/NCT07859150)
- TrialNew Semaglutide study registered: GLP-1 Receptor Agonist Use and Sarcopenia in Obese Individuals Without Diabetes (clinicaltrials.gov/study/NCT07858864)
- TrialNew Semaglutide study registered: Tapered Versus Abrupt Discontinuation of Semaglutide After Treatment of Recurrent Weight Gain or Suboptimal Response Following Metabolic and Bariatric Surgery (clinicaltrials.gov/study/NCT07859176)
Oct 2, 2026
- TrialNew Semaglutide study registered: SYNCHRONIZE®-START- A Study to Test Whether Survodutide Helps People Living With Overweight or Obesity Who do Not Have Diabetes to Lose Weight (clinicaltrials.gov/study/NCT07855900)
- TrialNew Semaglutide study registered: A Research Study Investigating How Adults With Overweight or Obesity, With or Without Type 2 Diabetes, Tolerate Switching to a New Treatment (Zenagamtide) From Their Current Semaglutide Medication (clinicaltrials.gov/study/NCT07855133)
Oct 1, 2026
- TrialSemaglutide study now active, not recruiting (was recruiting): DUTCH Weight Control in Atrial Fibrillation Study (clinicaltrials.gov/study/NCT06184633)
Sep 30, 2026
- TrialNew Semaglutide study registered: Real-World Patient and Physician Experience With Semaglutide Across Six Emerging Markets (clinicaltrials.gov/study/NCT07850765)
- TrialNew Survodutide study registered: ELEVATE-LIVER: A Study to Test Whether Survodutide Helps Improve Heart Structure and Function in People With Overweight or Obesity and Fatty Liver Disease (clinicaltrials.gov/study/NCT07850063)
- TrialNew Semaglutide study registered: Study on the Efficacy and Safety of Initial Combination of Finerenone and Semaglutide in Non-Diabetic Adult Patients With Obesity Complicated by Chronic Kidney Disease With Albuminuria (clinicaltrials.gov/study/NCT07849348)
- TrialSemaglutide study now active, not recruiting (was not yet recruiting): A Retrospective Real-World Cohort Study (clinicaltrials.gov/study/NCT07781371)
- TrialNew Survodutide study registered: SYNCHRONIZE®-HERA: A Study to Test Whether Survodutide Helps Women Who Are Living With Overweight or Obesity and Are Going Through or Have Finished Menopause, to Lose Weight (clinicaltrials.gov/study/NCT07850050)
Sep 29, 2026
- TrialNew Tirzepatide study registered: Tirzepatide Versus Positive Airway Pressure for the Treatment of Obstructive Sleep Apnoea (clinicaltrials.gov/study/NCT07846865)
- TrialResults posted for a Semaglutide study: Phase 2a Placebo-Controlled Study of VTX3232 Alone or in Combination With Semaglutide in Obesity (clinicaltrials.gov/study/NCT06771115)
- TrialNew Semaglutide study registered: NAION in Non-Diabetic Obese Patients Using GLP-1 Receptor Agonists: A Real-World Study (clinicaltrials.gov/study/NCT07846956)
- TrialNew Semaglutide study registered: Probiotics in Obese Patients Treated With Semaglutide (clinicaltrials.gov/study/NCT07847593)
- TrialNew Tirzepatide study registered: Effects of Tirzepatide on Gut Microbiota and Gastrointestinal Function After Drug Withdrawal in Obese Patients (clinicaltrials.gov/study/NCT07847515)
- TrialNew Semaglutide study registered: A Study to Learn About Switching to a Monthly Study Medicine Called Berobenatide (PF-08653944) to Help Keep Weight Off in People With Overweight or Obesity (clinicaltrials.gov/study/NCT07845500)
- TrialNew Semaglutide study registered: SEMAFORCRANIO : Multicenter, Double-blind, Parallel, Randomized Controlled Trial of the Efficacy of Semaglutide in Hypothalamic Obesity Secondary to Craniopharyngioma in Children Aged 12 to 17 Years (clinicaltrials.gov/study/NCT07845994)
- TrialNew Semaglutide study registered: A Research Study Looking Into How a High Dose of s.c. Semaglutide Works With Emptying of the Stomach in People With Excess Body Weight (clinicaltrials.gov/study/NCT07845578)
Sep 28, 2026
- TrialNew Mazdutide study registered: A Study of HRS-4729 Injection in Participants With Type 2 Diabetes (clinicaltrials.gov/study/NCT07843862)
Sep 25, 2026
- TrialNew Semaglutide study registered: Evaluate the Safety and Tolerability of Multiple Doses of JMT206 Injection in Obese Participants (clinicaltrials.gov/study/NCT07840729)
- TrialNew Tirzepatide study registered: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ASC35 Injection in Participants With Obesity or Overweight (clinicaltrials.gov/study/NCT07842640)
- TrialSemaglutide study now completed (was not yet recruiting): A Clinical Study Comparing Semaglutide Injection and Wegovy® for Weight Management in Obese Subjects (clinicaltrials.gov/study/NCT06738979)
Sep 24, 2026
- TrialNew VK2735 study registered: A Phase 1 Study of VK2735 in Obese Adults Without Comorbidities (clinicaltrials.gov/study/NCT07838740)
Sep 23, 2026
- TrialNew Semaglutide study registered: A Study Comparing the Effects of BGM0504 Injection and Semaglutide Injection on Obese Subjects. (clinicaltrials.gov/study/NCT07836140)
Sep 22, 2026
- TrialNew MariTide study registered: Comparing the Extent to Which Two Maridebart Cafraglutide Drug Products Are Made Available in the Body After a Single Subcutaneous Dose (clinicaltrials.gov/study/NCT07832799)
- TrialNew Dulaglutide study registered: Weekly GLP-1 Receptor Agonists in Obese Individuals Without Diabetes (clinicaltrials.gov/study/NCT07834398)
- TrialNew Tirzepatide study registered: Body Composition Changes After Initiation of GLP-1 Receptor Agonists in Adults With Obesity or Type 2 Diabetes (clinicaltrials.gov/study/NCT07835360)
Oct 9, 2024
- TrialSemaglutide study now unknown (was not yet recruiting): A Phase III Study Comparing the Weight Loss Effects of Semaglutide Injection and Wegovy® (clinicaltrials.gov/study/NCT06633783)
Sep 27, 2024
- TrialSemaglutide study now unknown (was not yet recruiting): Efficacy and Safety of Semaglutide for Weight Loss in Overweight or Obese Adults in Bangladesh With or Without Type 2 Diabetes Mellitus (clinicaltrials.gov/study/NCT06616961)
Mar 1, 2024
- TrialSemaglutide study now unknown (was not yet recruiting): Semaglutide 2.4mg for Low Responders After Bariatric Surgery (clinicaltrials.gov/study/NCT06287307)
Sources: Drugs@FDA, openFDA labels, shortages and enforcement reports, FDA press and MedWatch feeds, the Federal Register, ClinicalTrials.gov, Europe PMC and each seller's own price page. A recall number identifies a product, not a current status: confirm at the linked record. A study listed here is not a judgement of its quality. Nothing on this page is medical advice.